Slocum, Gordon & Co LLP ABBV Holdings History
Slocum, Gordon & Co LLP's AbbVie Inc Holding Summary
As of 2025-03-31, Slocum, Gordon & Co LLP held 21,400.00 shares of AbbVie Inc(ABBV), totaling $4.48 Mil. This investment constitutes 3.34% of their stock portfolio, and Slocum, Gordon & Co LLP now holds 0% of the outstanding AbbVie Inc(ABBV) stock.
The initial trade took place in 2023Q1. And since then Slocum, Gordon & Co LLP has made 1 purchases of ABBV, at an average price of $152.84, for a total of 43,654.00 shares. In addition, there have been 7 sales at an average price of $190.23 for 22,254.00 shares. Based on historical transaction data and ABBV's current price of $192.45, Slocum, Gordon & Co LLP's estimated gain on his ABBV holdings is $1.68 Mil, reflecting a 25.18% gain to date.
Slocum, Gordon & Co LLP ABBV ($192.45) Holding Chart
Slocum, Gordon & Co LLP ABBV ($192.45) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
